Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Tiragolumab and atezolizumab as 1L therapy for PD-L1-selected NSCLC Jun 02, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Analyzing Asian Patients in VISION Trial: Tepotinib for METex14 Skipping NSCLC Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Toripalimab vs. Placebo in Advanced NSCLC: Survival and Biomarker Analysis from CHOICE-01 Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Molecular Profiling Study of EGFR-Mutated NSCLC Patients Treated With 1L Osimertinib Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Amivantamab Plus Lazertinib in EGFR-Mutated NSCLC: Initial Results From CHRYSALIS-2 Jun 01, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Dose-Finding Phase 1B Study of Subcutaneous Atezolizumab in Advanced NSCLC May 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Results of Osimertinib Plus Platinum-Pemetrexed in Newly Diagnosed EGFR Mutation-Positive NSCLC May 30, 2023
Lung Cancer,NSCLC (Non-Small Cell Lung Cancer) Managing IRRs During Amivantamab Treatment in the CHRYSALIS Study May 30, 2023
